Skip to main content

Tecan and Dynal Biotech to Co-Develop Variety of Molecular Biology Applications

NEW YORK, Nov. 2 (GenomeWeb News) - Tecan and Dynal Biotech will co-develop and market optimized applications for separating, isolating, and manipulating biological material such as DNA, RNA, and proteins.


Under the terms of the non-exclusive agreement, which was originally announced on Oct. 15, the companies will develop applications using Dynal's Dynabeads magnetic bead kits and Tecan's Freedom EVO automated platform. Specific applications will include nucleic-acid extraction and preparation; PCR and sequencing clean-up procedures; and isolating recombinant proteins.


Financial details of the agreement were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.